Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques

Signal Transduct Target Ther. 2022 Jul 7;7(1):219. doi: 10.1038/s41392-022-01095-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing / pharmacology
  • Antibodies, Neutralizing / therapeutic use
  • Antibodies, Viral / therapeutic use
  • COVID-19*
  • Horses
  • Macaca mulatta
  • SARS-CoV-2

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral